Skip to main content

Enhanced immunity after Ad26.COV2.S vaccine breakthrough infection.

Publication ,  Journal Article
Montefiori, DC
Published in: Cell Rep Med
March 15, 2022

A study by Kitchin, Richardson et al. finds that breakthrough infection with the SARS-CoV-2 Delta variant in Ad26.COV2.S-vaccinated individuals induces strong neutralizing antibody responses against multiple variants, including the Omicron variant.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Cell Rep Med

DOI

EISSN

2666-3791

Publication Date

March 15, 2022

Volume

3

Issue

3

Start / End Page

100579

Location

United States

Related Subject Headings

  • Viral Vaccines
  • SARS-CoV-2
  • Humans
  • COVID-19
  • Antibodies, Viral
  • Ad26COVS1
  • 32 Biomedical and clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Montefiori, D. C. (2022). Enhanced immunity after Ad26.COV2.S vaccine breakthrough infection. Cell Rep Med, 3(3), 100579. https://doi.org/10.1016/j.xcrm.2022.100579
Montefiori, David C. “Enhanced immunity after Ad26.COV2.S vaccine breakthrough infection.Cell Rep Med 3, no. 3 (March 15, 2022): 100579. https://doi.org/10.1016/j.xcrm.2022.100579.
Montefiori DC. Enhanced immunity after Ad26.COV2.S vaccine breakthrough infection. Cell Rep Med. 2022 Mar 15;3(3):100579.
Montefiori, David C. “Enhanced immunity after Ad26.COV2.S vaccine breakthrough infection.Cell Rep Med, vol. 3, no. 3, Mar. 2022, p. 100579. Pubmed, doi:10.1016/j.xcrm.2022.100579.
Montefiori DC. Enhanced immunity after Ad26.COV2.S vaccine breakthrough infection. Cell Rep Med. 2022 Mar 15;3(3):100579.

Published In

Cell Rep Med

DOI

EISSN

2666-3791

Publication Date

March 15, 2022

Volume

3

Issue

3

Start / End Page

100579

Location

United States

Related Subject Headings

  • Viral Vaccines
  • SARS-CoV-2
  • Humans
  • COVID-19
  • Antibodies, Viral
  • Ad26COVS1
  • 32 Biomedical and clinical sciences